Paper30384792
Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations.
Grosse SD and 2 others. J Med Econ, 2019. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations. Papers, record 30384792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30384792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cost of Illness | Major topic |
| Efficiency | Major topic |
| Models, Economic | Major topic |
| Salaries and Fringe Benefits | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| Censuses | |
| Female | |
| Humans | |
| Life Tables | |
| Male | |
| Middle Aged | |
| United States | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CC999999 | Intramural CDC HHS | United States | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 30821543 | Correction. | https://conductscience.org/library/papers/30821543 |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10520672 | Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine. | Med Decis Making | 1999 | https://conductscience.org/library/papers/10520672 | PubMed |
| 2 | 12055046 | Economic gains resulting from the reduction in children's exposure to lead in the United States. | Environ Health Perspect | 2002 | https://conductscience.org/library/papers/12055046 | PubMed |
| 3 | 15748084 | Friction-cost method as an alternative to the human-capital approach in calculating indirect costs. | Pharmacoeconomics | 2005 | https://conductscience.org/library/papers/15748084 | PubMed |
| 4 | 16942122 | Cost-of-illness studies : a review of current methods. | Pharmacoeconomics | 2006 | https://conductscience.org/library/papers/16942122 | PubMed |
| 5 | 19536021 | Economic productivity by age and sex: 2007 estimates for the United States. | Med Care | 2009 | https://conductscience.org/library/papers/19536021 | PubMed |
| 6 | 19654928 | Childhood lead poisoning: conservative estimates of the social and economic benefits of lead hazard control. | Environ Health Perspect | 2009 | https://conductscience.org/library/papers/19654928 | PubMed |
| 7 | 19807446 | Cost-of-illness analyses for policy making: a cautionary tale of use and misuse. | Expert Rev Pharmacoecon Outcomes Res | 2003 | https://conductscience.org/library/papers/19807446 | PubMed |
| 8 | 19995754 | The value of productivity: human-capital versus friction-cost method. | Ann Rheum Dis | 2010 | https://conductscience.org/library/papers/19995754 | PubMed |
| 9 | 21146909 | Measuring and valuing productivity loss due to poor health: A critical review. | Soc Sci Med | 2011 | https://conductscience.org/library/papers/21146909 | PubMed |
| 10 | 2148306 | The lifetime cost of injury. | Inquiry | 1990 | https://conductscience.org/library/papers/2148306 | PubMed |
| 11 | 21545189 | Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. | Pharmacoeconomics | 2011 | https://conductscience.org/library/papers/21545189 | PubMed |
| 12 | 21604822 | Cost-of-illness studies: a guide to critical evaluation. | Pharmacoeconomics | 2011 | https://conductscience.org/library/papers/21604822 | PubMed |
| 13 | 22188353 | Economic burden of occupational injury and illness in the United States. | Milbank Q | 2011 | https://conductscience.org/library/papers/22188353 | PubMed |
| 14 | 24504850 | How to estimate productivity costs in economic evaluations. | Pharmacoeconomics | 2014 | https://conductscience.org/library/papers/24504850 | PubMed |
| 15 | 25781999 | The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review. | PLoS One | 2015 | https://conductscience.org/library/papers/25781999 | PubMed |
| 16 | 25876834 | A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. | Eur J Health Econ | 2016 | https://conductscience.org/library/papers/25876834 | PubMed |
| 17 | 26385101 | Cost-of-Illness Studies: An Updated Review of Current Methods. | Pharmacoeconomics | 2016 | https://conductscience.org/library/papers/26385101 | PubMed |
| 18 | 27161997 | Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women. | Vaccine | 2016 | https://conductscience.org/library/papers/27161997 | PubMed |
| 19 | 27623463 | Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. | JAMA | 2016 | https://conductscience.org/library/papers/27623463 | PubMed |
| 20 | 27873305 | Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States. | Health Serv Res | 2018 | https://conductscience.org/library/papers/27873305 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42771343 | Cost of a Measles Outbreak in an Urban Shelter. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42771343 | PubMed |
| 42617888 | Morbidity-Related Productivity Losses From Major Depressive Disorder Among U.S. Adults. | Am J Prev Med | 2026 | https://conductscience.org/library/papers/42617888 | PubMed |
| 42466506 | Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Methamphetamine-Associated Heart Failure in the United States. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42466506 | PubMed |
| 42188782 | Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188782 | PubMed |
| 42154427 | Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/42154427 | PubMed |
| 42099551 | Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study. | Lancet Reg Health Am | 2026 | https://conductscience.org/library/papers/42099551 | PubMed |
| 42071110 | Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities from a Targeted Literature Review and Expert Workshop. | Pharmacoecon Open | 2026 | https://conductscience.org/library/papers/42071110 | PubMed |
| 41823143 | The broad societal value of pembrolizumab for women's cancer in Canada. | Future Oncol | 2026 | https://conductscience.org/library/papers/41823143 | PubMed |
| 41746506 | Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/41746506 | PubMed |
| 41364049 | Productivity Losses From Substance Use Disorder in the U.S. in 2023. | Am J Prev Med | 2026 | https://conductscience.org/library/papers/41364049 | PubMed |
| 41345602 | Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States. | BMC Public Health | 2025 | https://conductscience.org/library/papers/41345602 | PubMed |
| 41288194 | Estimating Productivity Losses per HIV Infection due to Premature HIV Mortality in the United States. | Med Decis Making | 2026 | https://conductscience.org/library/papers/41288194 | PubMed |
| 41075052 | Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50-59 Years at Increased Risk of Severe RSV Disease. | Infect Dis Ther | 2025 | https://conductscience.org/library/papers/41075052 | PubMed |
| 40721584 | Cost-effectiveness of chikungunya vaccination with the live attenuated vaccine in U.S. territories. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40721584 | PubMed |
| 40699573 | Optimizing Timing for Respiratory Syncytial Virus Prevention Interventions for Infants. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40699573 | PubMed |
| 40553408 | Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations. | Pharmacoecon Open | 2025 | https://conductscience.org/library/papers/40553408 | PubMed |
| 40455586 | Economic burden of fungal diseases in the United States. | Med Mycol | 2025 | https://conductscience.org/library/papers/40455586 | PubMed |
| 40394570 | Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach. | BMC Public Health | 2025 | https://conductscience.org/library/papers/40394570 | PubMed |
| 40285335 | The "Stock of Time" Method: A New Approach to Calculate Indirect Costs and Benefits in Economic Evaluations. | Med Decis Making | 2025 | https://conductscience.org/library/papers/40285335 | PubMed |
| 40220866 | Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States. | Value Health | 2025 | https://conductscience.org/library/papers/40220866 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30384792
GET https://conductscience.org/api/papers/v1/30384792/references?page=2